Search research articles
Contact Us
Filters
Showing results (1-10 of 1,173) with videos related to
Page
of 118
Sort By:
Physical Review. D, Particles and Fields
|
January 15, 1995
Connection between the pinch technique and the background field method
Papavassiliou
Biomedicines
|
December 24, 2021
The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?
Kostas A Papavassiliou, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs
|
November 12, 2013
Histone deacetylases inhibitors: conjugation to other anti-tumour pharmacophores provides novel tools for cancer treatment
Konstantinos A Papavassiliou, Athanasios G Papavassiliou
Journal of Cellular and Molecular Medicine
|
June 1, 2024
Suv39h1: Targeting epigenetics to treat liver fibrosis
Kostas A Papavassiliou, Athanasios G Papavassiliou
Trends in Molecular Medicine
|
July 3, 2014
Bromodomains: pockets with therapeutic potential
Kostas A Papavassiliou, Athanasios G Papavassiliou
Cell Metabolism
|
June 5, 2024
Hungry for fat: Metabolic crosstalk with lipid-rich CAFs fuels pancreatic cancer
Kostas A Papavassiliou, Athanasios G Papavassiliou
Journal of Cellular Biochemistry
|
May 19, 2016
Transcription Factor Drug Targets
Kostas A Papavassiliou, Athanasios G Papavassiliou
Cancers
|
May 25, 2024
Up to the Herculean Task of Tackling Cancer Therapy Resistance
Kostas A Papavassiliou, Athanasios G Papavassiliou
Journal of Cellular and Molecular Medicine
|
February 12, 2021
Malignant circuits: Novel therapeutic opportunities in neuro-oncology
Kostas A Papavassiliou, Athanasios G Papavassiliou
JAMA Oncology
|
June 26, 2025
Shifting Toward Precision Oncology in SCLC Treatment
Kostas A Papavassiliou, Athanasios G Papavassiliou
Page
of 118
Search research articles
Search
Showing results (1-10 of 1,173) with videos related to
Sort By:
Page
of 118
Physical Review. D, Particles and Fields
|
January 15, 1995
Connection between the pinch technique and the background field method
Papavassiliou
Biomedicines
|
December 24, 2021
The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?
Kostas A Papavassiliou, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs
|
November 12, 2013
Histone deacetylases inhibitors: conjugation to other anti-tumour pharmacophores provides novel tools for cancer treatment
Konstantinos A Papavassiliou, Athanasios G Papavassiliou
Journal of Cellular and Molecular Medicine
|
June 1, 2024
Suv39h1: Targeting epigenetics to treat liver fibrosis
Kostas A Papavassiliou, Athanasios G Papavassiliou
Trends in Molecular Medicine
|
July 3, 2014
Bromodomains: pockets with therapeutic potential
Kostas A Papavassiliou, Athanasios G Papavassiliou
Cell Metabolism
|
June 5, 2024
Hungry for fat: Metabolic crosstalk with lipid-rich CAFs fuels pancreatic cancer
Kostas A Papavassiliou, Athanasios G Papavassiliou
Journal of Cellular Biochemistry
|
May 19, 2016
Transcription Factor Drug Targets
Kostas A Papavassiliou, Athanasios G Papavassiliou
Cancers
|
May 25, 2024
Up to the Herculean Task of Tackling Cancer Therapy Resistance
Kostas A Papavassiliou, Athanasios G Papavassiliou
Journal of Cellular and Molecular Medicine
|
February 12, 2021
Malignant circuits: Novel therapeutic opportunities in neuro-oncology
Kostas A Papavassiliou, Athanasios G Papavassiliou
JAMA Oncology
|
June 26, 2025
Shifting Toward Precision Oncology in SCLC Treatment
Kostas A Papavassiliou, Athanasios G Papavassiliou
Page
of 118